Primary Investigator: Kul Aggarwal, MD
Study Coordinator: Alisa Lau-Sieckman, RN
Status: Closed to enrollment; follow-up continues
Study Title: A multicenter, double-blind, randomized study to establish the clinical benefit and safety of Vytorin vs Simvastatin monotherapy in high risk subjects presenting with acute coronary syndrome.
Purpose: The purpose of this study is to compare two drugs, ezetimibe/simvastatin combination and simvastatin alone in patients who have had a recent heart attack or unstable chest pain. Patients will be followed to see if there is a difference in future cardiac events depending on which drug they are randomized to.
Call Alisa Lau-Sieckman (beeper 573-443-9259) and/or the on-call research nurse (on-call beeper 573-499-8084) or Dr. Aggarwal if subject is admitted to the hospital or for any questions regarding study medication.
,Jewellery UK Online
,Digital Camera Reviews
,Digital Camera Buying Guide
,Cheap WoW Gold
,Buy WoW Gold
,Diablo 3 Gold
,Diablo 3 Power Leveling
,Guild Wars 2 Gold
,Guild Wars 2 Power Leveling
,WoW Gold Kaufen